As observed in Figure 7A, Dual-RevCAR T cells armed with the combination of RevTM EGFR-7B6 + GD2-5B9 or RevTM EGFR-7B6 + GD2-IgG4-5B9 were able to induce significant tumor lysis. The gene discussed is EGFR; the disease is neoplasm.